col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


31 Results       Page 1

 [1] 
Elsevier: Genomics
  original article Date Title Authors   All Authors
1 [GO] 2026―Jan―05 Single cell transcriptomic atlas reveals distinct immune signatures following transfusion of COVID-19 convalescent plasma in severe COVID-19 Chengqi Gao, Wei Xiao, Chao Zhu, Mengwei Liu, Zhenguo Zeng, Kun Xiao, Kuai Yu
2 [GO] 2025―Jul―15 Evaluation of two SARS-CoV-2 whole genome amplification and sequencing workflows for genomic surveillance and outbreak analysis in the clinical microbiology laboratory David Panisello Yagüe, Andreu C. Pelegrin, Laia Soler, Antoni E. Bordoy, Sandra Martínez-Puchol, Gemma Clarà, et al. (+12)
3 [GO] 2022―Sep―28 Genomic and evolutionary study from SARS-CoV-2 virus isolates from Bangladesh during the early stage of pandemic strongly correlate with European origin and not with China Mohammad Fazle Alam Rabbi, Mala Khan, Mamudul Hasan Razu, Md. Imran Khan, Saam Hasan, Mauricio Chalita, et al. (+14)
4 [GO] 2022―Aug―27 SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength? Sheeba Saifi, Varsha Ravi, Sparsh Sharma, Aparna Swaminathan, Nar Singh Chauhan, Rajesh Pandey
5 [GO] 2022―Jun―06 First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome Ramesh Pandit, Indra Singh, Afzal Ansari, Janvi Raval, Zarna Patel, Raghav Dixit, et al. (+8)
6 [GO] 2021―Oct―28 Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy Erick Gustavo Dorlass, Karine Lima Lourenço, Rubens Daniel Miserani Magalhães, Hugo Sato, Alex Fiorini, Renata Peixoto, et al. (+10)
7 [GO] 2021―Aug―18 Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age Meng Wu, Lingwei Ma, Liru Xue, Qingqing Zhu, Su Zhou, Jun Dai, et al. (+3)
8 [GO] 2021―Jul―20 CoVrimer: A tool for aligning SARS-CoV-2 primer sequences and selection of conserved/degenerate primers Merve Vural, Aslinur Akturk, Mert Demirdizen, Ronaldo Leka, Rana Acar, Ozlen Konu
9 [GO] 2021―May―19 Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns Jayanta Kumar Das, Swarup Roy
10 [GO] 2021―May―15 Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries Rui Wang, Jiahui Chen, Kaifu Gao, Guo-Wei Wei
11 [GO] 2021―Apr―08 ACoRE: Accurate SARS-CoV-2 genome reconstruction for the characterization of intra-host and inter-host viral diversity in clinical samples and for the evaluation of re-infections Luca Marcolungo, Cristina Beltrami, Chiara Degli Esposti, Giulia Lopatriello, Chiara Piubelli, Antonio Mori, et al. (+15)
12 [GO] 2021―Apr―07 Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality Jahad Alghamdi, Manal Alaamery, Tlili Barhoumi, Mamoon Rashid, Hala Alajmi, Nasser Aljasser, et al. (+15)
13 [GO] 2021―Jan―20 Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID19 therapy Henry Sung-Ching Wong, Chin-Lin Guo, Gan-Hong Lin, Kang-Yun Lee, Yukinori Okada, Wei-Chiao Chang
14 [GO] 2020―Dec―28 Comprehensive analysis of TCR repertoire in COVID-19 using single cell sequencing Pingping Wang, Xiyun Jin, Wenyang Zhou, Meng Luo, Zhaochun Xu, Chang Xu, et al. (+8)
15 [GO] 2020―Dec―13 A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2 Umar Faruq Chowdhury, Mohammad Umer Sharif Shohan, Kazi Injamamul Hoque, Mirza Ashikul Beg, Mohammad Kawsar Sharif Siam, Mohammad Ali Moni
16 [GO] 2020―Nov―13 Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19 Gourab Das, Troyee Das, Nilkanta Chowdhury, Durbadal Chatterjee, Angshuman Bagchi, Zhumur Ghosh
17 [GO] 2020―Nov―05 Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus Chayan Roy, Santi M. Mandal, Suresh K. Mondal, Shriparna Mukherjee, Tarunendu Mapder, Wriddhiman Ghosh, Ranadhir Chakraborty
18 [GO] 2020―Oct―20 Variant analysis of the first Lebanese SARS-CoV-2 isolates Mhamad Abou-Hamdan, Kassem Hamze, Ali Abdel Sater, Haidar Akl, Nabil El-zein, Israa Dandache, Fadi Abdel-sater
19 [GO] 2020―Sep―30 Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection Azadeh Rahimi, Azin Mirzazadeh, Soheil Tavakolpour
20 [GO] 2020―Sep―20 Mutations on COVID-19 diagnostic targets Rui Wang, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
21 [GO] 2020―Sep―12 Molecular phylogeny and missense mutations of envelope proteins across coronaviruses Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy
22 [GO] 2020―Sep―10 SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design Sandeep Kumar Kushwaha, Veerbhan Kesarwani, Samraggi Choudhury, Sonu Gandhi, Shailesh Sharma
23 [GO] 2020―Sep―08 Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analysis Abdus Samad, Tamanna Jafar, Jahirul Hasnat Rafi
24 [GO] 2020―Aug―19 Missense mutations in SARS-CoV2 genomes from Indian patients Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy, Siddhartha Sankar Jana
25 [GO] 2020―Aug―07 Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach Pandiyan Muthuramalingam, Rajendran Jeyasri, Alaguvel Valliammai, Anthonymuthu Selvaraj, Chandrasekar Karthika, Shanmugaraj Gowrishankar, et al. (+3)
26 [GO] 2020―Jul―31 Probing antiviral drugs against SARS-CoV-2 through virus-drug association prediction based on the KATZ method Liqian Zhou, Juanjuan Wang, Guangyi Liu, Qingqing Lu, Ruyi Dong, Geng Tian, et al. (+2)
27 [GO] 2020―Jul―25 Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2 Namisha Sharma, Mehanathan Muthamilarasan, Ashish Prasad, Manoj Prasad
28 [GO] 2020―Jul―06 Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses Rabeb Touati, Sondes Haddad-Boubaker, Imen Ferchichi, Imen Messaoudi, Afef Elloumi Ouesleti, Henda Triki, et al. (+2)
29 [GO] 2020―Jul―05 SARS-CoV2 envelope protein: non-synonymous mutations and its consequences Sk. Sarif Hassan, Pabitra Pal Choudhury, Bidyut Roy
30 [GO] 2020―Jun―12 Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes Sk. Sarif Hassan, Pabitra Pal Choudhury, Pallab Basu, Siddhartha Sankar Jana
31 [GO] 2020―Apr―27 Genotyping coronavirus SARS-CoV-2: methods and implications Changchuan Yin
 [1] 

31 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.006 sec